Showing results (1791-1800 of 1,865) with videos related to

Sort By:
Pageof 187
The Lancet. Neurology|March 14, 2015
Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trialRonit M Pressler, Geraldine B Boylan, Neil Marlow, et al.
Nature Communications|July 26, 2020
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer modelsHyoung Kim, Haineng Xu, Erin George, et al.
The Lancet. Neurology|July 16, 2022
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trialAnders Svenningsson, Thomas Frisell, Joachim Burman, et al.
Journal of Medicinal Chemistry|February 28, 2018
Creation of a Novel Class of Potent and Selective MutT Homologue 1 (MTH1) Inhibitors Using Fragment-Based Screening and Structure-Based Drug DesignFredrik Rahm, Jenny Viklund, Lionel Trésaugues, et al.
Translational Animal Science|October 5, 2022
Synovex ONE Grower improves growth performance for at least 200 days in growing beef steers and heifers fed in confinement for slaughterJase J Ball, Patrick C Taube, John W Hallberg, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 21, 2025
Phase II study of the efficacy and safety of palbociclib in patients with recurrent ovarian cancerGottfried E Konecny, Tara M Davidson, Coriolan L Lebreton, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Lancet (London, England)|March 15, 2024
Lung-function trajectories: relevance and implementation in clinical practiceErik Melén, Rosa Faner, James P Allinson, et al.
Cancer Research Communications|August 23, 2024
Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA AnalysisTorben Ek, Raghda R Ibrahim, Hartmut Vogt, et al.
American Journal of Respiratory and Critical Care Medicine|July 31, 2023
Circulating CC16 and Asthma: A Population-based, Multicohort Study from Early Childhood through Adult LifeNipasiri Voraphani, Debra A Stern, Julie G Ledford, et al.
Pageof 187